Press Releases

Recro Pharma Announces Update on On-Going Phase II Clinical Trial of Dex-IN for Treatment of Acute Pain on Day 1 Following Surgery

Apr 09, 2015 11:00am EDT

Recro Pharma Reports Fourth Quarter and Full Year 2014 Financial Results

Mar 25, 2015 12:00pm EDT

Recro Pharma to Acquire IV/IM Meloxicam and Gainesville, GA GMP Manufacturing Facility and Business Unit From Alkermes

Mar 09, 2015 10:00am EDT

Recro Pharma Enters Into Common Stock Purchase Agreement With Aspire Capital

Feb 03, 2015 1:00pm EST

Recro Pharma to Present at the 17th Annual BIO CEO & Investor Conference

Feb 02, 2015 9:22pm EST

Recro Pharma Reports Third Quarter 2014 Financial Results

Nov 10, 2014 12:00pm EST

Recro Pharma Announces Dosing of First Patient in Phase II REC-14-013 Clinical Trial of Dex-IN for Treatment of Acute Pain on Day 1 Following Surgery

Oct 29, 2014 8:05pm EDT

Recro Pharma to Present at the 2014 Aegis Healthcare & Technology Conference

Sep 08, 2014 11:00am EDT

Recro Pharma Provides Clinical Strategy Update Following Interim Analysis for Phase IIb Clinical Trial of Dex-IN

Sep 04, 2014 8:51pm EDT

Recro Pharma Reports Second Quarter 2014 Financial Results

Aug 12, 2014 11:00am EDT

1...
8
9
10
11
12
13
14
15
16
17